Most Recent
In ordering early registration for a class action against a Johnson & Johnson unit, which estimates its defence costs at over $22 million, a judge has said the "very expensive" process is appropriate.
Johnson & Johnson has agreed to pay $7.9 billion to resolve multi-district litigation in the US alleging its talcum powder caused cancer, a settlement Shine Lawyers said was a positive development as it readies for a first case management hearing in its class action.
Defence lawyers are bracing for a wave of class actions over companies’ use of generative artificial intelligence, with privacy, discrimination, consumer, product liability and shareholder claims expected.
US drug maker Pfizer has been hit with a class action alleging it knew or ought to have known about the increased risk that patients who used its injectable contraceptive Depo-Provera could develop brain tumors.
A group member in a class action against Johnson & Johnson unit Depuy that resolved 14 years ago has successfully challenged his compensation award, with an appeals court finding the independent counsel who calculated his payout was bound by rules of procedural fairness.
A new class action has been launched on behalf of over 10,000 Chevrolet Silverado owners, following a global recall of the utes by General Motors.
Tesla can't escape a case by a motorist over his car's self-driving capabilities, despite overlap with a class action, with a tribunal saying there was no abuse of process while the driver could not opt out of the group proceeding.
GM can't strike out a class action over alleged faulty transmissions in Holden cars, with a judge saying the case doesn't need to identify the “precise mechanical, metallurgical or engineering explanation” for alleged defects.
Medical device maker Exactech will pay $8.7 million to end a class action that alleges its joint replacement implants were defective.
A class action investigation is underway into alleged links between the herbicide paraquat and Parkinson’s disease.